Investors

Press Releases

Endonovo Therapeutics Buys Back Convertible Note From Lender Avoiding Any Immediate Dilution
Endonovo Therapeutics Developing Next-Generation Cell Therapy for Acute and Chronic Graft-Versus-Host Disease Using Cell-Enhancing Cytotronics Platform
Endonovo Therapeutics Files Patent Application on Cell Therapy Created Using Its Proprietary Cell-Enhancing Cytotronics Platform
Endonovo Therapeutics Announces Immunotronic and Cytotronic Platforms
Endonovo Therapeutics Announces Method for Large Scale Expansion of Cord Blood
Endonovo Therapeutics Announces Corporate Patent Licensing Program
Endonovo Therapeutics Targets Non-Invasive Treatment for Acute and Chronic Inflammatory Conditions of the Liver
Endonovo Therapeutics Enters into a $3 Million Equity Purchase Agreement with Kodiak Capital Group, LLC
RSS